Novel, FDA-approved treatment for recurrent gynecologic cancer, in which all visible tumor is resected and the abdominal cavity is perfused with heated chemotherapy to enhance tumor kill and chemotherapy effect. We have provided HIPEC services under clinical trial setting since 2006, and were the first in the state of California.
Please see www.hipectreatment.com and HIPEC Clinical Trials for more details.
Proprietary, FDA-phase 1 experimental therapy for secondarily recurrent gynecologic cancer, in which the entire body is systemically heated to 42C and detoxified to effect tumor kill.
PHASE I completed. Trial currently closed.
Integrated, holistic clinical trials paradigm aimed at personal, customized treatment focusing on the cancer patient in addition to the cancer. The program is centered around modulation of inflammatory/immune response, dietary supplementation, physical therapy and real-time telemedicine visits. We are eager to enroll patients undergoing treatment or surveillance after completion of treatment for gynecologic cancers.
Please see www.coshire.com for more details.
Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Subjects with Uterine and Cervical Malignancies who are Undergoing Lymph Node Mapping: A collaborative international trial including MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Duke University, HIMA Puerto Rica, L’Hôtel-Dieu de Québec, and Sunnybrook Health Science Centre.
PENDING IRB approval.
Please see www.clinicaltrials.gov for more details.
schedule an appointment today